4Edmunds LH, Clark RE, Cohn LH, et al. Guidelines for morbidity and mortality after cardiac valvular operation. J Thorac Cardiovasc Surg, 1996,112:708-711.
5Bristow MR,Durham,J,Klein R,et al.Down-regulation of β-adrenergic receptor mRNA in heart cell chronically exposed to morepinephrine.Clin Res,1991,39∶256A
6Toshihiro O, Yoshiki S, Keishi K,et al. Effect of cardiopulmonary bypass under temperature on inflammatory reactions. J Ann Thorac Surg,1997,64:124-128.
7Selke FW, Shafique T, Johnson RG, et al. Blood and albumin cardioplegia preserve endothelium-dependent microvascular response. J Ann Thorac Surg,1993,55:977-985.
8Adams JE, Abendschein DR, Jaffe AS. Biochemical markers of myocardial injury. Is creatine kinase the choice for the 1990s. Circulation,1993,88:750-763.
3ANTUNES M J, BARLOW J B. Management of tricuspid valve regurgitation[J]. Heart, 2007, 93(2): 271-276.
4ALSOUFI B, RAO V, BORGER M A, et al. Short-and long- term results of triple valve surgery in the modern era [ J ]. Ann Thorac Surg, 2006, 81(6): 2172-2178.
5FILSOUFI F, ANYANWU A C, SALZBERG S P, et al. Long- term outcomes of tircuspid valve replacement in the current era [J]. Ann Thorac Surg, 2005, 80(3) : 845-850.
